NIGHTINGALE PATIENT PATHWAY AUTOMATION IS LIVE WITH NHS PRIMARY CARE!
PRECISION HEALTH DELIVERED
Nightingale - The most Advance
Patient Pathway Automation Solution is Live for NHS Primary Care with Extraordinary Results
Liberate AI Health Solutions
Nightingale Revolutionises Management of Patients with long term condtions
Nightingale Revolutionises Management of Patients with long term condtions
LiberateAI provides the most comprehensive Precision Health AI Solutions including:
Nightingale Patient Pathway Automation Solution
Proven in large scale NHS deployment, delivering spectacular results everyday
FRANKLIN Deep Patient Insights (DPI) and Demand Management Applications
Franklin DPI provides deep insights on Patients At Risk of Hospitalisation. Franklin Demand Management Application provides deep insights on the clinical demand and supply of clinical resources to address the demand.
MAXWELL Unified Primary and Secondary Care Health Data Vault
Secur Federated Health Data Platform is the foundation of all our solutuions
FLEMING Precision Health AI Platform
Enables the use of AI to identify At Risk Patients for proactive interventions. Fleming is the foundation of all our AI development and deployment solutions.
Nightingale Revolutionises Management of Patients with long term condtions
Nightingale Revolutionises Management of Patients with long term condtions
Nightingale Revolutionises Management of Patients with long term condtions
Nightingale Patient Pathway Automation is developed in collaboration with NHS Primary Care
Automating Complex Long Term Condition (LTC) Patient Pathways, with 100,000s of patients in the UK, already benefiting from faster access to care, ease of access through digital channel and prioritisation based on their level of risk
Primary Care Clinics using Nightingale benefit from doubling of their appointment capacity for patients with LTCs, 35% reduction in waiting times and more than 90% reduction in the number of calls and administrative work load
In 2025, Nightingale is Automating care for Asthma, Diabetes, CKD, CHD,
COPD, and Hypertension and many more LTC Pathways in 2026